These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11257677)

  • 1. Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma.
    Rini BI; Zimmerman TM; Gajewski TF; Stadler WM; Vogelzang NJ
    J Urol; 2001 Apr; 165(4):1208-9. PubMed ID: 11257677
    [No Abstract]   [Full Text] [Related]  

  • 2. Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma.
    Motzer RJ; Hutson TE; Ren M; Dutcus C; Larkin J
    Lancet Oncol; 2016 Jan; 17(1):e4-5. PubMed ID: 26758760
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor treatment of metastatic renal cell carcinoma : Comparison of immunotherapy with other drug options].
    Uhlig A
    Urologe A; 2019 Oct; 58(10):1208-1211. PubMed ID: 31471642
    [No Abstract]   [Full Text] [Related]  

  • 4. Metastatic renal cell carcinoma: systemic treatment.
    Abi-Aad AS; deKernion JB
    Acta Urol Belg; 1996 May; 64(2):3-8. PubMed ID: 8701805
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
    Tykodi SS; Warren EH; Thompson JA; Riddell SR; Childs RW; Otterud BE; Leppert MF; Storb R; Sandmaier BM
    Clin Cancer Res; 2004 Dec; 10(23):7799-811. PubMed ID: 15585611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
    Childs R; Chernoff A; Contentin N; Bahceci E; Schrump D; Leitman S; Read EJ; Tisdale J; Dunbar C; Linehan WM; Young NS; Barrett AJ
    N Engl J Med; 2000 Sep; 343(11):750-8. PubMed ID: 10984562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of mediastinal metastasis of renal small cell carcinoma, performing CHOP therapy for an acute respiratory failure by the air way obstruction under the mechanical ventilation].
    Fujisawa T; Aoshima M; Uchiyama N; Satoh T; Ohmagari N; Chonabayashi N; Saiki S; Suzuki K
    Nihon Kokyuki Gakkai Zasshi; 2003 Jul; 41(7):440-6. PubMed ID: 12931670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy.
    Ueno NT; Cheng YC
    Bone Marrow Transplant; 2006 Dec; 38(11):711-4. PubMed ID: 17106451
    [No Abstract]   [Full Text] [Related]  

  • 9. Complete response after sequential sunitinib-sorafenib treatment in a patient with renal cell carcinoma: a case report.
    Verzoni E; Lanocita R; Procopio G
    Clin Genitourin Cancer; 2012 Jun; 10(2):130-3. PubMed ID: 22226825
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysis.
    Thiery-Vuillemin A; Montange D; Kalbacher E; Maurina T; Nguyen T; Royer B; Bouchet S; Bazan F; Curtit E; Pivot X
    Ann Oncol; 2011 Sep; 22(9):2152-2154. PubMed ID: 21878429
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic stem-cell transplantation in renal-cell carcinoma.
    Hayes-Lattin BM; Maziarz RT; Beer TM
    Curr Oncol Rep; 2001 Sep; 3(5):433-7. PubMed ID: 11489245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor.
    Mankoff DA; Thompson JA; Gold P; Eary JF; Guinee DG; Samlowski WE
    AJR Am J Roentgenol; 1997 Oct; 169(4):1049-50. PubMed ID: 9308463
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunotherapeutic treatment for metastatic renal carcinoma].
    Hidalgo Pardo F; Gutiérrez Sanz-Gadea C; Rebassa Llull MJ; García Bueno JM; Mus Malleu A; Losada González GP; Ozonas Moragues M
    Actas Urol Esp; 1998 Jan; 22(1):29-33. PubMed ID: 9542189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metastatic nephrocarcinoma: regression after peripheral lymphocyte transplantation from compatible donors].
    Roseau E
    Presse Med; 2000 Nov; 29(35):1937-8. PubMed ID: 11244625
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer immunotherapy with alloreactive lymphocytes.
    Slavin S
    N Engl J Med; 2000 Sep; 343(11):802-3. PubMed ID: 10984570
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
    Pandha H
    Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemoimmunotherapy of metastatic renal cell carcinoma.
    Bukowski RM
    Cancer Invest; 1999; 17(6):460-1. PubMed ID: 10434957
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma.
    Childs RW
    Crit Rev Immunol; 2001; 21(1-3):191-203. PubMed ID: 11642604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European studies of interleukin-2 in metastatic renal cell carcinoma.
    Atzpodien J; Kirchner H; Hänninen EL; Körfer A; Fenner M; Menzel T; Deckert M; Franzke A; Jonas U; Poliwoda H
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):22-6. PubMed ID: 8284688
    [No Abstract]   [Full Text] [Related]  

  • 20. Is cytotoxic chemotherapy effective in the treatment of advanced renal cell carcinoma?
    Swanson DA
    Semin Urol; 1993 Feb; 11(1):35-40. PubMed ID: 7682003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.